169 related articles for article (PubMed ID: 25805930)
21. Protective effect of bicyclol on acute hepatic failure induced by lipopolysaccharide and D-galactosamine in mice.
Wang H; Li Y
Eur J Pharmacol; 2006 Mar; 534(1-3):194-201. PubMed ID: 16487963
[TBL] [Abstract][Full Text] [Related]
22. Tamoxifen Attenuates Lipopolysaccharide/Galactosamine-induced Acute Liver Failure by Antagonizing Hepatic Inflammation and Apoptosis.
Zhang P; Zhang M; Wan M; Huang X; Jiang Y; Xu S; Luo M
Immunol Invest; 2017 Apr; 46(3):284-294. PubMed ID: 27967264
[TBL] [Abstract][Full Text] [Related]
23. A glutamine synthetase inhibitor increases survival and decreases cytokine response in a mouse model of acute liver failure.
Jambekar AA; Palma E; Nicolosi L; Rasola A; Petronilli V; Chiara F; Bernardi P; Needleman R; Brusilow WS
Liver Int; 2011 Sep; 31(8):1209-21. PubMed ID: 21745296
[TBL] [Abstract][Full Text] [Related]
24. Enhanced renal sensitivity of the spontaneously hypertensive rat to urotensin II.
Abdel-Razik AE; Balment RJ; Ashton N
Am J Physiol Renal Physiol; 2008 Oct; 295(4):F1239-47. PubMed ID: 18701623
[TBL] [Abstract][Full Text] [Related]
25. Rotenone, a mitochondrial respiratory complex I inhibitor, ameliorates lipopolysaccharide/D-galactosamine-induced fulminant hepatitis in mice.
Ai Q; Jing Y; Jiang R; Lin L; Dai J; Che Q; Zhou D; Jia M; Wan J; Zhang L
Int Immunopharmacol; 2014 Jul; 21(1):200-7. PubMed ID: 24830863
[TBL] [Abstract][Full Text] [Related]
26. Erythropoietin increases survival and attenuates fulminant hepatic failure injury induced by D-galactosamine/lipopolysaccharide in mice.
Ben-Ari Z; Zilbermints V; Pappo O; Avlas O; Sharon E; Greif F; Cheporko Y; Ravid A; Shapiro R; Hochhauser E
Transplantation; 2011 Jul; 92(1):18-24. PubMed ID: 21516061
[TBL] [Abstract][Full Text] [Related]
27. Sesamin ameliorates lipopolysaccharide/d-galactosamine-induced fulminant hepatic failure by suppression of Toll-like receptor 4 signaling in mice.
Ma L; Gong X; Kuang G; Jiang R; Chen R; Wan J
Biochem Biophys Res Commun; 2015 May; 461(2):230-6. PubMed ID: 25866179
[TBL] [Abstract][Full Text] [Related]
28. Urotensin II receptor (UTR) exists in hyaline chondrocytes: a study of peripheral distribution of UTR in the African clawed frog, Xenopus laevis.
Konno N; Fujii Y; Imae H; Kaiya H; Mukuda T; Miyazato M; Matsuda K; Uchiyama M
Gen Comp Endocrinol; 2013 May; 185():44-56. PubMed ID: 23399967
[TBL] [Abstract][Full Text] [Related]
29. Endotoxin tolerance alleviates experimental acute liver failure via inhibition of high mobility group box 1.
Yang NB; Ni SL; Li SS; Zhang SN; Hu DP; Lu MQ
Int J Clin Exp Pathol; 2015; 8(8):9062-71. PubMed ID: 26464648
[TBL] [Abstract][Full Text] [Related]
30. Protective effect of neutrophil elastase inhibitor (FR136706) in lethal acute liver failure induced by D-galactosamine and lipopolysaccharide in rats.
Uchida Y; Kaibori M; Hijikawa T; Ishizaki M; Ozaki T; Tanaka H; Matsui K; Tokuhara K; Kwon AH; Kamiyama Y; Okumura T
J Surg Res; 2008 Mar; 145(1):57-65. PubMed ID: 17936791
[TBL] [Abstract][Full Text] [Related]
31. The peptide compound urantide regulates collagen metabolism in atherosclerotic rat hearts and inhibits the JAK2/STAT3 pathway.
Wang T; Sun X; Cui H; Liu K; Zhao J
Mol Med Rep; 2020 Mar; 21(3):1097-1106. PubMed ID: 32016456
[TBL] [Abstract][Full Text] [Related]
32. Urotensin receptor antagonist urantide improves atherosclerosis-related kidney injury by inhibiting JAK2/STAT3 signaling pathway in rats.
Wang T; Xie YQ; Miao GX; Cui HP; Liu K; Li Y; Li Y; Zhao J
Life Sci; 2020 Apr; 247():117421. PubMed ID: 32061865
[TBL] [Abstract][Full Text] [Related]
33. Suramin prevents fulminant hepatic failure resulting in reduction of lethality through the suppression of NF-kappaB activity.
Goto T; Takeuchi S; Miura K; Ohshima S; Mikami K; Yoneyama K; Sato M; Shibuya T; Watanabe D; Kataoka E; Segawa D; Endo A; Sato W; Yoshino R; Watanabe S
Cytokine; 2006 Jan; 33(1):28-35. PubMed ID: 16413198
[TBL] [Abstract][Full Text] [Related]
34. Urotensin II: lessons from comparative studies for general endocrinology.
Lu W; Abdel-Razik AE; Ashton N; Balment RJ
Gen Comp Endocrinol; 2008 May; 157(1):14-20. PubMed ID: 18440535
[TBL] [Abstract][Full Text] [Related]
35. Etoposide prevents apoptosis in mouse liver with D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality.
Nakama T; Hirono S; Moriuchi A; Hasuike S; Nagata K; Hori T; Ido A; Hayashi K; Tsubouchi H
Hepatology; 2001 Jun; 33(6):1441-50. PubMed ID: 11391533
[TBL] [Abstract][Full Text] [Related]
36. Receptor activator of nuclear factor-κB ligand is a novel inducer of myocardial inflammation.
Ock S; Ahn J; Lee SH; Park H; Son JW; Oh JG; Yang DK; Lee WS; Kim HS; Rho J; Oh GT; Abel ED; Park WJ; Min JK; Kim J
Cardiovasc Res; 2012 Apr; 94(1):105-14. PubMed ID: 22298642
[TBL] [Abstract][Full Text] [Related]
37. Urantide decreases hepatic steatosis in rats with experimental atherosclerosis via the MAPK/Erk/JNK pathway.
Cui H; Lin Y; Xie L; Zhao J
Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33604686
[TBL] [Abstract][Full Text] [Related]
38. Urotensin II induces activation of NLRP3 and pyroptosis through calcineurin in cardiomyocytes.
Liang Y; Wu X; Xu M; Ding L; Li H; Wu Y
Peptides; 2021 Oct; 144():170609. PubMed ID: 34242679
[TBL] [Abstract][Full Text] [Related]
39. [Protective effect of recombinant HMGB1 A box protein in mouse with acute hepatic failure].
Liu T; He YW
Zhonghua Gan Zang Bing Za Zhi; 2010 Mar; 18(3):222-6. PubMed ID: 20380802
[TBL] [Abstract][Full Text] [Related]
40. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
